David AltsHuler, EVP and Chief Scientific Officer at Vertex Pharmaceuticals ($VRTX), made one open market sale of company shares in the last year, totaling about $22,000. His most recent VRTX insider sale occurred on May 15, 2025. This ranks 10,985th among 11,678 insiders by sales value, well below the average of $8.6 million across about 6 sales per insider. AltsHuler reported no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 22, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | ALTSHULER DAVID | EVP, Chief Scientific Officer | A | Common Stock | 7866 | $0.00 | 31,149.0000 | 258,000,000 | 33.78% | 0.00% |
| Jan. 22, 2026 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | ALTSHULER DAVID | EVP, Chief Scientific Officer | A | Common Stock | 3328 | $0.00 | 34,477.0000 | 258,000,000 | 10.68% | 0.00% |
| May 15, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | ALTSHULER DAVID | EVP, Chief Scientific Officer | S | Common Stock | 52 | $424.69 | 23,281.0000 | 257,899,999 | 0.22% | 0.00% |
| March 13, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | ALTSHULER DAVID | EVP, Chief Scientific Officer | S | Common Stock | 3231 | $510.00 | 23,281.0000 | 257,899,999 | 12.19% | 0.00% |
| March 10, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | ALTSHULER DAVID | EVP, Chief Scientific Officer | S | Common Stock | 3231 | $500.00 | 26,512.0000 | 257,899,999 | 10.86% | 0.00% |
| March 3, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | ALTSHULER DAVID | EVP, Chief Scientific Officer | S | Common Stock | 3231 | $490.00 | 29,743.0000 | 257,899,999 | 9.80% | 0.00% |
| Feb. 26, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | ALTSHULER DAVID | EVP, Chief Scientific Officer | F | Common Stock | 5954 | $479.61 | 34,246.0000 | 257,899,999 | 14.81% | 0.00% |
| Feb. 27, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | ALTSHULER DAVID | EVP, Chief Scientific Officer | S | Common Stock | 1272 | $480.00 | 32,974.0000 | 257,899,999 | 3.71% | 0.00% |
| Feb. 24, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | ALTSHULER DAVID | EVP, Chief Scientific Officer | F | Common Stock | 3971 | $483.28 | 41,048.0000 | 257,899,999 | 8.82% | 0.00% |
| Feb. 25, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | ALTSHULER DAVID | EVP, Chief Scientific Officer | S | Common Stock | 848 | $480.95 | 40,200.0000 | 257,899,999 | 2.07% | 0.00% |
| Feb. 20, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | ALTSHULER DAVID | EVP, Chief Scientific Officer | S | Common Stock | 1111 | $480.00 | 45,019.0000 | 257,899,999 | 2.41% | 0.00% |
| Feb. 14, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | ALTSHULER DAVID | EVP, Chief Scientific Officer | F | Common Stock | 2293 | $463.46 | 46,130.0000 | 257,899,999 | 4.74% | 0.00% |
| Feb. 12, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | ALTSHULER DAVID | EVP, Chief Scientific Officer | A | Common Stock | 5324 | $0.00 | 48,423.0000 | 257,899,999 | 12.35% | 0.00% |
| Feb. 10, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | ALTSHULER DAVID | EVP, Chief Scientific Officer | F | Common Stock | 2142 | $467.98 | 43,099.0000 | 257,899,999 | 4.73% | 0.00% |
| Feb. 4, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | ALTSHULER DAVID | EVP, Chief Scientific Officer | A | Common Stock | 7114 | $0.00 | 45,241.0000 | 257,899,999 | 18.66% | 0.00% |
| Feb. 4, 2025 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | ALTSHULER DAVID | EVP, Chief Scientific Officer | A | Common Stock | 12314 | $0.00 | 38,127.0000 | 257,899,999 | 47.70% | 0.00% |
| Nov. 15, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | ALTSHULER DAVID | EVP, Chief Scientific Officer | S | Common Stock | 15 | $478.56 | 25,813.0000 | 261,000,000 | 0.06% | 0.00% |
| May 15, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | ALTSHULER DAVID | EVP, Chief Scientific Officer | S | Common Stock | 54 | $430.93 | 25,813.0000 | 260,500,000 | 0.21% | 0.00% |
| Feb. 23, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | ALTSHULER DAVID | EVP, Global Research and CSO | F | Common Stock | 3970 | $431.79 | 30,052.0000 | 260,500,000 | 11.67% | 0.00% |
| Feb. 26, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | ALTSHULER DAVID | EVP, Global Research and CSO | S | Common Stock | 4239 | $425.70 | 25,813.0000 | 260,500,000 | 14.11% | 0.00% |
| Feb. 21, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | ALTSHULER DAVID | EVP, Global Research and CSO | S | Common Stock | 3002 | $421.77 | 34,022.0000 | 260,500,000 | 8.11% | 0.00% |
| Feb. 20, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | ALTSHULER DAVID | EVP, Global Research and CSO | S | Common Stock | 4002 | $420.79 | 37,024.0000 | 260,500,000 | 9.75% | 0.00% |
| Feb. 20, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | ALTSHULER DAVID | EVP, Global Research and CSO | F | Common Stock | 2812 | $420.58 | 41,026.0000 | 260,500,000 | 6.41% | 0.00% |
| Feb. 16, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | ALTSHULER DAVID | EVP, Global Research and CSO | F | Common Stock | 3750 | $424.01 | 43,838.0000 | 260,500,000 | 7.88% | 0.00% |
| Feb. 9, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | ALTSHULER DAVID | EVP, Global Research and CSO | F | Common Stock | 2099 | $422.74 | 50,733.0000 | 260,500,000 | 3.97% | 0.00% |
| Feb. 12, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | ALTSHULER DAVID | EVP, Global Research and CSO | S | Common Stock | 3145 | $420.24 | 47,588.0000 | 260,500,000 | 6.20% | 0.00% |
| Feb. 6, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | ALTSHULER DAVID | EVP, Global Research and CSO | A | Common Stock | 5814 | $0.00 | 37,852.0000 | 260,500,000 | 18.15% | 0.00% |
| Feb. 6, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | ALTSHULER DAVID | EVP, Global Research and CSO | A | Common Stock | 7866 | $0.00 | 45,718.0000 | 260,500,000 | 20.78% | 0.00% |
| Feb. 7, 2024 | VERTEX PHARMACEUTICALS INC / MA | $VRTX | ALTSHULER DAVID | EVP, Global Research and CSO | A | Common Stock | 7114 | $0.00 | 52,832.0000 | 260,500,000 | 15.56% | 0.00% |